The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field
AIDS Research and Therapy volume 14, Article number: 49 (2017)
Circumcision reduces heterosexual HIV-1 acquisition in men by at least 60%. However, the biological mechanisms by which circumcision is protective remain incompletely understood. We test the hypothesis that the sub-preputial microenvironment created by the foreskin drives immune activation in adjacent foreskin tissues, facilitating HIV-1 infection through a combination of epithelial barrier disruption, enhanced dendritic cell maturation, and the recruitment/activation of neutrophils and susceptible CD4 T cell subsets such as Th17 cells. Furthermore, we provide evidence that the genital microbiome may be an important driver of this immune activation. This suggests that new modalities to reduce genital immune activation and/or alter the genital microbiome, used alone or in combination with topical microbicides, may be of significant benefit to HIV prevention.
Male circumcision reduces HIV-1 (HIV) infection in heterosexual men by approximately 60% . However, the biological mechanism by which circumcision confers this protection remains poorly understood. The foreskin constitutes a fold of skin that covers the coronal sulcus, glans, and urethral meatus of the non-erect penis, and the distal aspect of the penile shaft on the erect penis. While the foreskin is one continuous sheet of skin, the portion of the foreskin that lies against the glans on the non-erect penis is referred to as the “inner” foreskin, while that which is exposed to the air at all times is referred to as the “outer” foreskin. The folding of the foreskin on the non-erect penis creates a sub-preputial space between the inner foreskin and glans that is largely anaerobic, and which is eliminated on the erect penis. By removing the foreskin surgically, circumcision permanently eliminates the sub-preputial space and exposes the glans to air on both the erect and non-erect penis.
Early speculation as to the protective biological mechanism of circumcision assumed that the relatively sheltered inner foreskin had a thinner layer of keratin (stratum corneum) than the outer foreskin and the penile shaft. Keratin is an insoluble layer of non-viable cells that limits the diffusion of HIV into the underlying living tissue, reducing access to HIV-susceptible cells , and so removing tissue with a thinner keratin layer would plausibly protect against HIV. However, subsequent studies quantifying the depth of stratum corneum have not found consistent differences between the inner and outer foreskin [3,4,5,6,7], and so this is unlikely to be the mechanism.
An alternative hypothesis is that elimination of the sub-preputial space reduces HIV susceptibility by altering the local immune environment of the penile skin. Productive infection after sexual exposure to HIV is relatively rare, with significant heterogeneity in susceptibility between individuals . Additionally, despite the swarm of virus quasispecies that is present in an infected partner’s genital secretions, only a single viral strain establishes systemic infection . This suggests that the establishment of productive infection in genital tissue constitutes a considerable barrier to the virus, and data from our group and others demonstrate that the local genital immune milieu is a major component of this barrier.
Models of SIV transmission in the female genital tract show that infection begins with the establishment of a productive focus of infected CD4 T-cells that expands through local viral replication, followed by systemic dissemination after several days . Genital immune activation may facilitate this process through several mechanisms. The first is through a reduction in the barrier function of genital tissue. In men, virus is able to enter foreskin tissue both through passive diffusion across the epithelium  and through active transport by migrating dendritic cells, which can transfer infectious virions to dermal CD4 T-cells . Initial penetration of virions across the stratum corneum is inefficient , but local inflammation in the skin disrupts the epithelial barrier through tissue remodeling, with increased HIV penetration at areas of decreased gap junction proteins . Similarly, vaginal inflammation in women is associated with decreased epidermal cell differentiation and cornified envelope pathways , which may reduce barrier integrity and enhance virus penetration.
Inflammation also has important effects on genital immune cells that may enhance HIV acquisition. Not only do local inflammatory signals enhance dendritic cell migration and increase trans infection of T-cells [13, 14], but immune activation also increases both the number and HIV-permissiveness of genital CD4 T-cells. This would be expected to stochastically increase the likelihood of productive infection after HIV exposure and, in keeping with this, the number of mucosal CCR5/CD4+ T-cells is a key determinant of macaque susceptibility after rectal SIV challenge , and larger foreskin size is associated with increased risk of HIV acquisition in adult men . Activated CD4 T-cells are also more permissive to infection and produce more virus than resting cells, with specific CD4 T-cell subsets being preferential HIV targets . Not only do Th17 cells express high levels of CCR5 and demonstrate enhanced in vitro HIV susceptibility [18, 19], but this subset comprises almost two-thirds of early SIV-infected cells in the genital tract of female macaques , despite the relative rarity of Th17 cells in genital tissue (<20% of CD4 T-cells [18, 20, 21]). Further evidence that Th17 cells are central to genital HIV susceptibility comes from individuals who are Highly Exposed to HIV but remain SeroNegative (HESN): HESN men have a reduced relative abundance of Th17 cells in their foreskin tissues , and HESN women demonstrate reduced genital expression of Th17 cytokines .
Longitudinal studies clearly confirm the importance of genital immune activation in HIV susceptibility. Uncircumcised men who acquired HIV were more likely to have had preceding high levels of the chemokines IL-8 and Monokine Induced by interferon-gamma (MIG) in their sub-preputial space than those who remained uninfected . IL-8 is produced by epithelial and other cells and is best known for its recruitment of neutrophils, which provide an important defense against extracellular pathogens partially through the recruitment of Th17 cells [25, 26], and IL-8 concentrations in the sub-preputial space correlated with the density of both neutrophils and Th17 cells in foreskin tissue . Furthermore, men who acquired HIV had higher preceding levels of innate anti-microbial proteins in their sub-preputial space, particularly of neutrophil-derived α-defensins . While some of these innate molecules have anti-HIV activity in vitro, they also act as pro-inflammatory signaling molecules, promoting epithelial remodeling and inflammation, which may overshadow any anti-HIV activity [28, 29].
Based on these data, our overall hypothesis is that circumcision reduces HIV susceptibility by reducing local inflammation in penile tissues, preventing loss of barrier integrity and reducing HIV-target cell density in exposed skin. While it is not feasible to prove this by obtaining paired skin biopsies from a man’s penis pre- and post-circumcision, coronal sulcus IL-8 levels progressively decline for at least 2 years after circumcision . In addition, several studies have compared immune cells between the inner and outer aspects of foreskin tissue, under the assumption that the latter would resemble the penile shaft skin that remains after circumcision. The inner foreskin harbors an increased density of CD4 T-cells [2, 7] and releases increased levels of pro-inflammatory cytokines [7, 30]. In situ explant studies show that dendritic cells from the inner foreskin demonstrate increased environmental sampling  and are better able to transfer infectious HIV to dermal T-cells , a characteristic of dendritic cells that have been matured through exposure to bacterial antigens [13, 14, 30]. Therefore it seems that tissues adjacent to the sub-preputial space (i.e. the inner foreskin) display a pro-inflammatory environment that is more conducive to HIV, and that circumcision eliminates the sub-preputial space and reduces this local immune activation.
If this hypothesis is true, then what causes the pro-inflammatory immune milieu that is seen in foreskin tissues adjacent to the sub-preputial space? Emerging evidence suggests that both co-infections and the local polymicrobial community (the penile microbiome) play a key role. Circumcision reduces the incidence of viral co-infections, particularly human papilloma virus (HPV) and herpes simplex virus type 2 (HSV-2) . HSV-2 infection increases HIV risk, both in individuals with ulcerative disease where there is long-lasting tissue infiltration of activated CD4 T-cells , and also in asymptomatic men where it induces inflammatory foci and the selective foreskin recruitment of CCR5+ CD4 T-cells [34, 35]. HPV is also associated with HIV acquisition, perhaps because host HPV clearance is associated with an increased density of dendritic cells in both the foreskin  and female genital tract [37, 38]. However, the protective effect of circumcision against HIV infection is far greater than can be explained by a reduction in these viral co-infections alone ; another important mechanism by which circumcision may reduce penile inflammation is through the dramatic alterations that it induces in the penile microbiome [40, 41].
Over 42 distinct bacterial families can be found in the sub-preputial space of uncircumcised men, and gram-negative anaerobic genera that are associated with bacterial vaginosis in women are common . For instance, Prevotella spp. were present in the foreskin prepuce of 87% of uncircumcised Ugandan men, where they constituted over 20% of the total bacterial load, and their abundance was increased (by 4.6 × 105 16S rRNA gene copies per swab) in the foreskin of men whose female sexual partner had BV . Furthermore, there was a strong association in uncircumcised Ugandan men between the presence of BV-associated anaerobes in the foreskin prepuce and subsequent HIV acquisition. For instance, preputial Prevotella spp. were associated with an increased risk of HIV acquisition (adjusted OR 1.63, 95% CI 1.23–2.26), and their density was almost tenfold higher in men who acquired HIV (1.5 × 108 vs. 1.9 × 107 rRNA gene copies per swab in controls) , which is very analogous to BV-associated increases in female HIV susceptibility [44, 45]. These anaerobes were observed in the absence of penile symptoms, but their abundance correlated strongly with preputial levels of IL-8 (P < 0.01) and with the simultaneous detection of multiple chemokines (OR 4.8, 95% CI 2.4–9.6) , strongly suggesting that preputial anaerobes induce a local inflammatory response. However, while their causal role in driving genital inflammation in women has been demonstrated through the dramatic immune alterations induced by BV therapy , the direction of causality in men has not been defined, and may require clinical trials to assess the immune impact of microbiome-directed interventions.
Circumcision reduces both the total bacterial load on the penis and also specifically reduces the relative abundance of these anaerobic genera associated with HIV acquisition [40, 41]. Significant penile microbiome changes are apparent within 6 months of circumcision , and anaerobes continue to decline significantly for at least 2 years post-operatively, mirroring the progressive declines seen in IL-8 levels . While vaginal bacterial dysbiosis is accepted as a driver of vaginal inflammation [47, 48] and HIV acquisition , the concept that penile bacterial dysbiosis may also drive inflammation and HIV acquisition is new. Coupled with the observation that the genital microbiome is shared between sexual partners, these observations have important implications for HIV prevention, but it remains to be shown whether they can be translated into prevention methods that extend beyond male circumcision. Specifically, because substantial HIV risk remains after circumcision and many at-risk men in HIV endemic regions choose to remain uncircumcised , it will be important to assess whether HIV risk can be reduced through clinical interventions that target penile immunology and/or the penile microbiome, both in uncircumcised but also circumcised men. Furthermore, it will important for preclinical and early phase clinical trials of novel HIV prevention methods, including HIV vaccines that aim to induce mucosal immune responses, to define intervention impacts on both genital inflammation and the genital microbiome.
In summary, we hypothesize that immune activation in foreskin tissues adjacent to the sub-preputial space facilitates HIV infection through a combination of epithelial barrier disruption, enhanced dendritic cell maturation, and the recruitment/activation of neutrophils and susceptible CD4 T-cell subsets such as Th17 cells, and that the genital microbiome may be an important driver of this immune activation. It might appear that understanding these mechanisms would be a moot point for men who undergo circumcision, but since circumcision is only 60% protective against HIV acquisition, it is possible—or even probable—that similar mechanisms underpin their residual HIV susceptibility, as well as HIV susceptibility in women. Therefore, new modalities to reduce genital immune activation and/or alter the genital microbiome, used alone or in combination with topical microbicides, may be of significant benefit in HIV prevention.
human immunodeficiency virus-1
sexually transmitted infection
genital ulcer disease
herpes simplex virus type 2
human papilloma virus
simian immunodeficiency virus
monokine induced by interferon-gamma
helper T cell
HIV exposed SeroNegative
Tobian AA, Kacker S, Quinn TC. Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med. 2014;65:293–306.
Dinh MH, Anderson MR, McRaven MD, Cianci GC, McCoombe SG, Kelley ZL, Gioia CJ, Fought AJ, Rademaker AW, Veazey RS, et al. Visualization of HIV-1 interactions with penile and foreskin epithelia: clues for female-to-male HIV transmission. PLoS Pathog. 2015;11(3):e1004729.
Dinh MH, Hirbod T, Kigozi G, Okocha EA, Cianci GC, Kong X, Prodger JL, Broliden K, Kaul R, Serwadda D, et al. No difference in keratin thickness between inner and outer foreskins from elective male circumcisions in Rakai, Uganda. PLoS ONE. 2012;7(7):e41271.
Dinh MH, McRaven MD, Kelley ZL, Penugonda S, Hope TJ. Keratinization of the adult male foreskin and implications for male circumcision. Aids. 2010;24(6):899–906.
Qin Q, Zheng X-Y, Wang Y-Y, Shen H-F, Sun F, Ding W. Langerhans’ cell density and degree of keratinization in foreskins of Chinese preschool boys and adults. Int Urol Nephrol. 2009;41(4):747–53.
McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS. 2006;20(11):1491–5.
Lemos MP, Lama JR, Karuna ST, Fong Y, Montano SM, Ganoza C, Gottardo R, Sanchez J, McElrath MJ. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier. PLoS ONE. 2014;9(9):e108954.
Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8(6):447–57.
Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA. 2008;105(21):7552–7.
Haase AT. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med. 2011;62(1):127–39.
Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, et al. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. J Virol. 2009;83(11):5592–605.
Arnold KB, Burgener A, Birse K, Romas L, Dunphy LJ, Shahabi K, Abou M, Westmacott GR, McCorrister S, Kwatampora J, et al. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol. 2015;9(1):194.
de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human langerhans cells ex vivo. J Clin Invest. 2008;118(10):3440–52.
Fahrbach KM, Barry SM, Ayehunie S, Lamore S, Klausner M, Hope TJ. Activated CD34-derived Langerhans cells mediate trans infection with human immunodeficiency virus. J Virol. 2007;81(13):6858–68.
Carnathan DG, Wetzel KS, Yu J, Lee ST, Johnson BA, Paiardini M, Yan J, Morrow MP, Sardesai NY, Weiner DB, et al. Activated CD4+ CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques. Proc Natl Acad Sci USA. 2015;112(2):518–23.
Kigozi G, Wawer M, Ssettuba A, Kagaayi J, Nalugoda F, Watya S, Mangen FW, Kiwanuka N, Bacon MC, Lutalo T, et al. Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS. 2009;23(16):2209–13
McKinnon LR, Kaul R. Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Curr Opin HIV AIDS. 2012;7(2):195–202.
McKinnon LR, Nyanga B, Chege D, Izulla P, Kimani M, Huibner S, Gelmon L, Block KE, Cicala C, Anzala AO, et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol. 2011;187(11):6032–42.
Gosselin A, Monteiro P, Chomont N, Diaz-Griffero F, Said EA, Fonseca S, Wacleche V, El-Far M, Boulassel MR, Routy JP, et al. Peripheral blood CCR4+ CCR6+ and CXCR3+ CCR6+ CD4+ T cells are highly permissive to HIV-1 infection. J Immunol. 2010;184(3):1604–16.
Stieh DJ, Matias E, Xu H, Fought AJ, Blanchard JL, Marx PA, Veazey RS, Hope TJ. Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques. Cell Host Microbe. 2016;19(4):529–40.
Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Hirbod T, Wawer M, Hofer SO, Sewankambo N, Serwadda D, et al. Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol. 2012;5(2):121–8.
Prodger JL, Hirbod T, Kigozi G, Nalugoda F, Reynolds SJ, Galiwango R, Shahabi K, Serwadda D, Wawer MJ, Gray RH, et al. Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda. Mucosal Immunol. 2014;7(3):634–44.
Chege D, Chai Y, Huibner S, Kain T, Wachihi C, Kimani M, Barasa S, McKinnon LR, Muriuki FK, Kariri A, et al. Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya. PLoS ONE. 2012;7(8):e43670.
Prodger JL, Gray RH, Shannon B, Shahabi K, Kong X, Grabowski K, Kigozi G, Nalugoda F, Serwadda D, Wawer MJ, et al. Chemokine levels in the penile coronal sulcus correlate with HIV-1 acquisition and are reduced by male circumcision in Rakai, Uganda. PLoS Pathog. 2016;12(11):e1006025.
Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 2010;115(2):335–43.
Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332(6025):65–8.
Hirbod T, Kong X, Kigozi G, Ndyanabo A, Serwadda D, Prodger JL, Tobian AA, Nalugoda F, Wawer MJ, Shahabi K, et al. HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog. 2014;10(10):e1004416.
Venkataraman N, Cole AL, Svoboda P, Pohl J, Cole AM. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol. 2005;175(11):7560–7.
Wahl SM, McNeely TB, Janoff EN, Shugars D, Worley P, Tucker C, Orenstein JM. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis. 1997;3(Suppl 1):S64–9.
Zhou Z, de Longchamps NB, Schmitt A, Zerbib M, Vacher-Lavenu MC, Bomsel M, Ganor Y. HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog. 2011;7(6):e1002100.
Fahrbach KM, Barry SM, Anderson MR, Hope TJ. Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin’s role in HIV transmission. Mucosal Immunol. 2010;3(4):410–8.
Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu MC, Gibault L, Thiounn N, Tomasini J, Wolf JP, Bomsel M. Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages langerhans–T cell conjugates. Mucosal Immunol. 2010;3(5):506–22.
Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med. 2009;15(8):886–92.
Johnson KE, Redd AD, Quinn TC, Collinson-Streng AN, Cornish T, Kong X, Sharma R, Tobian AAR, Tsai B, Sherman ME, et al. Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda. J Infect Dis. 2011;203(5):602–9.
Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Nehemiah K, Kakanga M, Hirbod T, Wawer MJ, Sewankambo N, et al. Impact of asymptomatic herpes simplex virus-2 infection on T cell phenotype and function in the foreskin. AIDS. 2012;26(10):1319–22.
Tobian AA, Grabowski MK, Kigozi G, Redd AD, Eaton KP, Serwadda D, Cornish TC, Nalugoda F, Watya S, Buwembo D, et al. Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin. J Infect Dis. 2013;207(11):1713–22.
Shannon B, Yi TJ, Perusini S, Gajer P, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol. 2017. doi:10.1038/mi.2016.129.
Scott ME, Shvetsov YB, Thompson PJ, Hernandez BY, Zhu X, Wilkens LR, Killeen J, Vo DD, Moscicki AB, Goodman MT. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer. 2013;133(5):1187–96.
Gray RH, Serwadda D, Tobian AA, Chen MZ, Makumbi F, Suntoke T, Kigozi G, Nalugoda F, Iga B, Quinn TC, et al. Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: analyses from the Rakai trials. PLoS Med. 2009;6(11):e1000187.
Liu CM, Hungate BA, Tobian AA, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. mBio. 2013. doi:10.1128/mBio.00076-13.
Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, Bowers J, Ravel J, Keim PS, Serwadda D, Wawer MJ, et al. The effects of circumcision on the penis microbiome. PLoS ONE. 2010;5(1):e8422.
Liu CM, Hungate BA, Tobian AA, Ravel J, Prodger JL, Serwadda D, Kigozi G, Galiwango RM, Nalugoda F, Keim P, et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. mBio. 2015;6(3):e00589.
Liu CM, Prodger JL, Tobian A, Abraham A, Kigozi G, Hungate BA, Aziz M, Nalugoda F, Sariya S, Serwadda D et al. Penile anaerobic dysbiosis as a risk factor for HIV infection. mBio. 2017; (in press).
Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis. 2005;192(8):1372–80.
Gosmann C, Anahtar MN, Handley SA, Farcasanu M, Abu-Ali G, Bowman BA, Padavattan N, Desai C, Droit L, Moodley A, et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity. 2017;46(1):29–37.
Joag V, Onyang JO, Dizzell S, Angote P, Anyango K, Gathee C, Kyambi N, Shahabi K, Huibner S, Oyugi J et al. Impact of effective bacterial vaginosis treatment on genital immunology and the epithelial barrier (Late Breaker). In: HIV research for prevention (R4P), Chicago, USA, 17–21 Oct 2016.
Anahtar MN, Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, Padavattan N, Ismail N, Moodley A, Sabatini ME, et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015;42(5):965–76.
Shannon B, Gajer P, Yi TJ, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W, et al. Distinct effects of the cervico-vaginal microbiota and herpes simplex type 2 infection on female genital tract immunology. J Infect Dis. 2017;215(9):1366–75.
Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, Hayes RJ, Baeten JM, Brown J, Delany-Moretlwe S, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 2011;8(2):e1000416.
Gray RH, Wawer MJ, Kigozi G. Programme science research on medical male circumcision scale-up in sub-Saharan Africa. Sex Transm Infect. 2013;89(5):345–9.
JP: manuscript preparation/editing; RK: manuscript preparation/editing. Both authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
Consent for publication
Ethics approval and consent to participate
Canadian Institutes of Health Research (RK, TMI-138656). The funding body had no role in study design; data collection, analysis, or interpretation; nor in writing the manuscript.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Prodger, J.L., Kaul, R. The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field. AIDS Res Ther 14, 49 (2017). https://doi.org/10.1186/s12981-017-0167-6